|
| Press Releases |
|
 |
|
| Monday, November 7, 2022 |
|
|
Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH |
| Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon in Asia (9 countries/regions*) to a subsidiary of DKSH Holding Ltd more info >> |
|
|
エーザイ、筋緊張改善剤「ミオナール(R)」、めまい・平衡障害治療剤「メリスロン(R)」についてアジアにおける権利をDKSHに譲渡 |
| エーザイ株式会社は、このたび、筋緊張改善剤「ミオナール(R)」（一般名：エペリゾン塩酸塩）、および めまい・平衡障害治療剤「メリスロン(R)」（一般名：ベタヒスチンメシル酸塩）について、アジア（９カ国・地域*）における権利を DKSH Holding Ltd.の子会社に譲渡する契約を締結したことをお知らせします。 more info >> |
|
| Friday, November 4, 2022 |
|
|
エーザイ、タイにおいてThai Life Insuranceとアルツハイマー病をはじめとする認知症の治療に対するアクセス支援に向けた協働について合意 |
| エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、当社のタイ販売子会社である Eisai（Thailand）Marketing Co., Ltd., （以下 エーザイ・タイランド）がタイの大手生命保険会社である Thai Life Insurance Public Company Limited（本社：タイ バンコク、Director & CEO：Chai Chaiyawan、以下 Thai Life Insurance）と、タイにおけるアルツハイマー病をはじめとする認知症の治療に対するアクセス支援に向け協働することに合意したことをお知らせします。 more info >> |
|
|
Eisai's Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer's Disease, in Thailand |
| Eisai Co., Ltd. announced today that its Thai sales subsidiary Eisai (Thailand) Marketing Co. Ltd. ("Eisai Thailand") made an agreement to collaborate in supporting access to treatments for dementia, including Alzheimer's disease, in Thailand with Thai Life Insurance Public Company Limited, a leading life insurance company in Thailand. more info >> |
|
| Wednesday, November 2, 2022 |
|
|
Eisai Satisfies All-case Study Requirement for Antiepileptic Agent Inovelon |
| Eisai Co., Ltd. announced today that it has received notification from Japan's Ministry of Health, Labour, and Welfare (MHLW) that the "all-case study" specified post-marketing observational study condition. more info >> |
|
|
Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination |
| Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a treatment for Alzheimer's disease and dementia with Lewy bodies that was discovered and developed in-house, has been granted Category 2* status based on the results of a reexamination of its efficacy, dosage and administration for the treatment of dementia with Lewy bodies (DLB) in Japan. more info >> |
|
| Monday, October 31, 2022 |
|
|
エーザイ、「アリセプト(R)」について日本のレビー小体型認知症に係る適応に関する再審査結果に伴う用法・用量の一部変更申請の予定について発表 |
| エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、本日、自社創製のアルツハイマー型認知症・レビー小体型認知症治療剤「アリセプト(R)」（一般名：ドネペジル塩酸塩）について、日本におけるレビー小体型認知症（DLB）に係る効能・効果および用法・用量に関する再審査の結果、カテゴリー2*となった旨の通知を受領しました。 more info >> |
|
| Tuesday, October 4, 2022 |
|
|
Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan |
| Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Future & Beyond", it has completed construction of the new injection/research building "Eisai Medicine Innovation Technology Solutions" ("EMITS") at the Kawashima Industrial Park located in Gifu Prefecture, Japan. more info >> |
|
|
エーザイ、川島工園において新注射剤棟/研究棟が竣工 |
| エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、当社の中期経営計画 EWAY Future & Beyond における戦略投資の一環として、川島工園（岐阜県）において建設中であった新注射剤棟/研究棟（名称：Eisai Medicine Innovation Technology Solutions、以下 EMITS）が竣工したことをお知らせします。 more info >> |
|
| Wednesday, September 28, 2022 |
|
|
Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint |
| Eisai Co., Ltd. and Biogen Inc. announced positive topline results from Eisai's large global Phase 3 confirmatory Clarity AD clinical trial of lecanemab. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
PropertyGuru Asia Real Estate Summit spotlights PropertyGuru Week 2025 with conversations on 'Trusted Marketplaces and Thriving Communities'
Dec 18, 2025 09:00 HKT/SGT
|
|
|
TruMerit 與 NAPNAP 攜手開發全球性小微認證，專注於兒科護理照護領域
Dec 18, 2025 07:00 HKT/SGT
|
|
|
TruMerit与NAPNAP携手开发全球儿科护理微认证
Dec 18, 2025 07:00 HKT/SGT
|
|
|
TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care
Dec 18, 2025 07:00 HKT/SGT
|
|
|
1World Online and Culinary Heritage Announce Strategic Partnership and Joint Launches in Europe
Dec 17, 2025 23:29 HKT/SGT
|
|
|
キリンと富士通、創薬DX技術を活用し、AIと実試験でシチコリンの腸脳作用メカニズムを解明
Dec 17, 2025 15:30: JST
|
|
|
マツダ、「D&I AWARD」において最上位「ベストワークプレイス」に2年連続認定
Dec 17, 2025 12:00: JST
|
|
|
Anson Resources: Update on Cooperation between Anson and POSCO Holdings for DLE Green River Demonstration Plant
Dec 17, 2025 07:00 HKT/SGT
|
|
|
AWM 以多座衝浪場館盛大開幕，為 2025 年劃下完美句點
Dec 16, 2025 23:05 HKT/SGT
|
|
|
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings
Dec 16, 2025 23:05 HKT/SGT
|
|
|
伊士曼、阿斯特捷利康、卡夫亨氏與寶潔榮獲OMP供應鏈大獎
Dec 16, 2025 22:00 HKT/SGT
|
|
|
伊士曼、阿斯利康、卡夫亨氏和宝洁荣获OMP供应链大奖
Dec 16, 2025 22:00 HKT/SGT
|
|
|
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
Dec 16, 2025 22:00 HKT/SGT
|
|
|
Doubleview Gold Corp Extends Mineralization East of 2024 Conceptual Pit and Identifies Deeper Porphyry Indicators at Hat Project by Drilling 992m of 0.29% CuEq in Hole H101
Dec 16, 2025 20:29 HKT/SGT
|
|
|
美國馬球協會棕櫚灘馬拉松於佛羅里達州西棕櫚灘創下破紀錄的週末盛事
Dec 16, 2025 20:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
